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The Stroke Riskometer mobile application is a novel, validated way to provide personalized stroke 
risk assessment for individuals and motivate them to reduce their risks. Although this app is being 
used worldwide, its reliability across different countries has not yet been rigorously investigated 
using appropriate methodology. The Generalizability Theory (G‑Theory) is an advanced statistical 
method suitable for examining reliability and generalizability of assessment scores across different 
samples, cultural and other contexts and for evaluating sources of measurement errors. G‑Theory 
was applied to the Stroke Riskometer data sampled from 1300 participants in 13 countries using 
two‑facet nested observational design (person by item nested in the country). The Stroke Riskometer 
demonstrated strong reliability in measuring stroke risks across the countries with coefficients G 
relative and absolute of 0.84, 95%CI [0.79; 0.89] and 0.82, 95%CI [0.76; 0.88] respectively. D‑study 
analyses revealed that the Stroke Riskometer has optimal reliability in its current form in measuring 
stroke risk for each country and no modifications are required. These results suggest that the Stroke 
Riskometer’s scores are generalizable across sample population and countries permitting cross‑
cultural comparisons. Further studies investigating reliability of the Stroke Riskometer over time in 
longitudinal study design are warranted.
Stroke is the second leading cause of death and the third leading cause of disability  worldwide1. The number 
of incident strokes has been increasing dramatically from approximately 7.2 million people in 1990 to 12.2 
million in 2019 (69% increase), while the number of stroke survivors over that time period has increased from 
54.7 million to 101.5 million (86%)1. Stroke is no longer a disease of older people like it was 30–40 years ago, 
with a significant increase in incidence rates in people 20–54 years old. Now more than 60% of people affected 
by stroke are younger than 75  years2. These data indicate that the burden of stroke is more likely to surge in the 
future even though stroke is highly  preventable2 and that currently used primary stroke prevention strategies 
are not sufficiently  effective3. If more affordable and effective prevention strategies were implemented, the stroke 
burden could be substantially decreased.
Currently, personal modern technologies (e.g., Smartphones) are used worldwide with increasing numbers of 
users, allowing increased productivity and convenience. One of the important advantages of far reaching mobile 
health applications (apps) is that they can offer personalized assessments that may provide novel opportunities 
to enhance individuals’ health and reduce the burden of many diseases including  stroke4,5. Mobile apps can be 
both accessible and cost‐effective (free to use). There is evidence that using the relevant Smartphone applica-
tions elicit behavior change in preventing  stroke4,5. The National Institute for Stroke and Applied Neurosciences 
(NISAN) at Auckland University of Technology (AUT University) has developed a free to use mobile app called 
the Stroke  Riskometer6. Figure 1 shows the front page of the app, which utilizes the international guidelines 
on stroke prevention to increase awareness about the disease and its risk factors on an individual  level7. The 
algorithm which is used in the Stroke Riskometer was adapted from the Framingham Stroke Risk Score (FSRS) 
prediction  algorithm8 by adding additional important (primarily lifestyle) risk factors and properly  validated9.
The Stroke Riskometer comprises 21 assessment items including three demographic questions (i.e. age, sex, 
and ethnicity/race), two physical questions (height and weight) and 16 questions about other major risk factors 
of stroke including blood  pressure6,10. The application computes absolute stroke risk estimates in 5- and 10-year 
perspective for users aged 20–93. Importantly, this application also provides the relative risk calculation for 
stroke, which allows users to compare their stroke risk against a person of the same demographic characteristics 
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such as age, sex and ethnicity without contributing risk factors. Relative risk estimates of the app were shown to 
be acceptable and motivational to the user to know their risk factors and how to control  them3,11, thus allowing 
stroke prevention interventions regardless of the level of risk as recommended by the World Stroke Organiza-
tion and the World Heard  Federation12. The Stroke Riskometer covers all stroke risk levels and alerts users to 
reduce their risk of  stroke9.
The Stroke Riskometer was validated by Parmar et al.9 using Classical Test Theory (CTT) methods. In that 
study, the authors explored the predictive validity of this application to stroke risk by comparing the use of this 
application to the other two common methods (i.e. FSRS and QStroke). The results of the study indicated that 
the Stroke Riskometer is as accurate as FSRS and  QStroke13 in predicting  stroke9. A recent pilot randomized 
controlled trial (RCT) conducted by Krishnamurthi et al.11 to examine feasibility and preliminary efficacy of the 
Stroke Riskometer (n = 26) app for primary stroke prevention compared to usual care (n = 24) demonstrated a 
high acceptability and clinically significant efficacy of the intervention to improve cardiovascular health 6 months 
post-randomization.
Even though the Stroke Riskometer is a novel stroke prevention tool with growing evidence supporting its 
reliability and validity in estimating stroke risks, this Smartphone application should be continually developed 
and validated to improve the accuracy of its scoring  systems9. In addition, this application was developed in New 
Zealand, but its users are located worldwide. Therefore, research should assess the psychometric properties of this 
application across countries to establish robustness of the instrument by utilizing an appropriate methodology 
such as Generalizability theory (G-Theory)14,15.
G-Theory represents an extension of the widely used CTT methodology in examining the reliability, evaluat-
ing sources of measurement error and establishing generalizability of assessment  scores15–19. While CTT consid-
ers that error variance of any measurement is a single source, G-Theory estimates all potential sources of error 
variance that may influence the accuracy of the  measurement14,15,19. CTT methods examine reliability of only 
one aspect of a measurement at a time (e.g. internal consistency Cronbach’s alpha or test–retest), which reflects 
a reliable measure with a coefficient of above 0.7020. Thus, CTT methods do not simultaneously consider specific 
measurement errors due to different sources of variability. In contrast, G-Theory closely examines all potential 
sources of error variance that may influence reliability  simultaneously14,16,17. These variance sources may include 
effects of person, country, instrument items used in each country, and interaction effects of person and country 
and person and item within a specific  country15. Therefore, G-Theory provides a more robust approach to evaluate 
precision of psychometric measurements across different situations and contexts (e.g. across cultures/countries). 
Figure 1.  Stroke Riskometer mobile application front page.
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To date, G-Theory has been applied to establish reliability and generalizability of assessment scores across many 
different disciplines including  medicine21,  rehabilitation22,  psychology17,  psychiatry23 and  education18.
The Stroke Riskometer app used in non-English speaking countries was translated into the languages of those 
countries, but the algorithm remained the same as the English version of the app. Therefore, the perception of 
the translated questions in the app might be different in people of different countries due to possible translation 
inaccuracy and/or different cultural norms. Thus, cross-country validation of the Stroke Riskometer is important 
and adds to the validity of the mobile tool. Currently, there is limited evidence to support reliability, validity and 
generalizability of the Stroke Riskometer app scores in measuring the risk of stroke across different countries. 
The aim of the present study was to use G-Theory analyses to assess reliability of the Stroke Riskometer and gen-
eralizability of its assessment scores across countries, and evaluate potential sources of measurement error. The 
application of G-Theory in this study involved a Generalizability study (G-study) and a Decision study (D-study). 
The purpose of the G-study was to evaluate the overall generalizability and sources of error variance of the Stroke 
Riskometer. The D-study was subsequently conducted to examine psychometric properties of individual items 
of the scale and evaluate reliability of the scale for each country, as well as the impact of one or more countries 
on the overall reliability of the Stroke  Riskometer15,29.
Results
G‑Study. Table 1 presents G-study results including the overall reliability and generalizability of scores across 
people, items nested in countries and countries. Both relative and absolute G coefficients were 0.84 and 0.82 (Gr 
and Ga, respectively), indicating strong reliability. The results showed that there were only two main sources of 
error variance. After accounting for the true variance of person, the largest source of error was the interaction 
between person and item nested in country Px(I:C), which accounted for 84.3% of the total error variance fol-
lowing by item nested in country (I:C) that explained the remaining 15.7% of measurement error in the current 
design.
D‑Study. Figures 2 and 3 display relative and absolute G coefficients of the Stroke Riskometer respectively, 
computed for each country including 95% confidence intervals. As can be seen, reliability was consistently high 
across the countries. Gr ranged from 0.83 to 0.84 and Ga ranged between 0.80 and 0.81 for all thirteen countries 
demonstrating strong cross-cultural reliability and generalizability of the Stroke Riskometer scores. As expected, 
all Ga were slightly lower with larger confidence intervals compared to Gr for all countries but the ranges of 
95% confidence intervals of both Ga and Gr for all countries were acceptable, further supporting reliability and 
generalizability of assessment scores across persons, items and countries. For instance, all lower bounds were 
above 0.76 for Gr and above 0.73 for Ga. 
We also examined the impact on the overall reliability of the scale after excluding a specific country and 
some countries randomly. There were only negligible differences in overall reliability estimates when conducting 
G-analyses after removing one country at a time, but all G coefficients were 0.80 or above, which is considered a 
good reliability. However, reliability coefficients decreased when we randomly removed more than one country at 
a time. When about half of the countries were removed (6 out of 13), Gr dropped to the level of 0.72 which is still 
acceptable for trait measures (Table 3). G coefficients computed for individual countries were acceptable, indicat-
ing that cross-cultural validation requires at least 10 countries to ensure robustness of the results. In addition, we 
then conducted analyses to examine the impact of ethnicities on the overall reliability of the scale. We analysed 
subsamples representing Caucasians including France, Italy, Russia, United Kingdom, Australia, Ukraine, New 
Zealand and the United States and non-Caucasians including Brazil, Kazakhstan, Malaysia, Nigeria and India. 
Generalizability coefficients from these subsamples range from 0.79 to 0.82 suggesting acceptable generaliz-
ability across these two general ethnic groups. Such minor differences in coefficients found between Caucasians 
and non-Caucasians are likely to be due to reduced number of facets (e.g. country) and different sample sizes 
because G-coefficients are sensitive to the number of facets and sample size. We also investigated the influence 
Table 1.  G-study estimates for the Stroke Riskometer including standard errors (SE), grand mean (GM), 
standard error of the grand mean, Coefficient G relative (Gr), Coefficient G absolute (Ga), and variance 
components for the design of P × (I:C) (n = 1300).
Source of variance
Differentiation 





P 0.004 … …
… (I:C) … 0.000 15.7
… C … (0.000) 0.0
… P × (I:C) 0.001 100.0 0.001 84.3
… P × C (0.000) 0.0 (0.000) 0.0
Sum of variances 0.004 0.001 100% 0.001 100%
Standard deviation 0.064 Relative SE: 0.028 Absolute SE: 0.030
Coefficient G 
relative 0.84 95% CI [0.79; 0.89] Grand mean for levels used: 0.227
Coefficient G 
absolute 0.82 95% CI [0.76; 0.88] Standard error of the grand mean: 0.014
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of sex, age, weight and height on the Stroke Riskometer assessment scores with the full sample. The results indi-
cated no significant effects of these factors on assessment scores across countries and consequently no effect on 
G-coefficients reflecting the reliability of the instrument. These outcomes together with other D-study results 
indicate that the Stroke Riskometer is reliable in estimating stroke risk with assessment scores are generalizable 
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Table 2 illustrates an additional series of generalizability analyses by excluding one item at a time for the 
Stroke Riskometer—we examined if this might result in improved reliability of the scale in measuring stroke risks. 
D-study results of these analyses include variance components attributed to person, item nested in country, and 
their interaction together with reliability estimates Gr and Ga. The first analysis was conducted by subtracting the 
first item (item 1), with subsequent analyses subtracting the next item from all other items. The results showed 
that the main source of error variance across all analyses was the interaction between person and item nested 
in country which accounted for more than 83.8% of the total error variance not including the true variance of 
person. In addition, we also conducted further analyses to examine the impact on the overall reliability of the 
scale after randomly excluding some items at a time and found that the more items excluded, the lower the reli-
ability coefficients (Table 3). There was no noticeable improvement of G-coefficients observed across analyses of 
the Stroke Riskometer indicating that removing any item did not improve its reliability, or even make it slightly 
worse. These results suggest that the Stroke Riskometer is the most reliable with its current measurement design 
including all 16 items tested.
Discussion
The aim of this study was to examine the reliability of the Stroke Riskometer across countries using G-Theory. 
The results showed that the Stroke Riskometer is reliable and consistent in estimating stroke risk across 13 
countries with G-coefficients of 0.80 and higher, meaning that the scores assessed by the Stroke Riskometer are 
generalizable across persons, items and countries. Our results also indicated that the scores were mainly affected 
by measurement error due to interaction between person and item nested in country (84.3%), which represented 
the highest percentage of the error variance in this study. This error may be attributed to translation of items 
into different languages and cross-cultural differences in interpreting specific items by completing assessments 
without health professional advice. The remaining 15.7% of measurement error was explained by items used in 
different countries. However, the impact of these errors on the overall strong reliability of the Stroke Riskometer 
was negligible with all G-coefficients of 0.80 or  above15,24.
Table 2.  D-study reliability estimates and variance components for the Person (P) × Item (I): Country (C) 
design including interactions for the Stroke Riskometer with removing one item at a time.
Removing item
P (I:C) P × (I:C)
Gr Gaσ2 σ2 % σ2 %
1 0.004 0.000 15.5 0.001 84.5 0.84 0.81
2 0.004 0.000 15.7 0.001 84.3 0.83 0.80
3 0.004 0.000 15.7 0.001 84.3 0.83 0.80
4 0.004 0.000 16.1 0.001 83.9 0.83 0.81
5 0.004 0.000 16.0 0.001 84.0 0.83 0.80
6 0.004 0.000 15.8 0.001 84.2 0.84 0.81
7 0.004 0.000 15.7 0.001 84.3 0.83 0.80
8 0.004 0.000 15.8 0.001 84.2 0.83 0.81
9 0.004 0.000 15.5 0.001 84.5 0.83 0.81
10 0.004 0.000 15.9 0.001 84.1 0.83 0.80
11 0.004 0.000 15.6 0.001 84.4 0.83 0.80
12 0.004 0.000 15.8 0.001 84.2 0.83 0.81
13 0.004 0.000 15.8 0.001 84.2 0.83 0.80
14 0.004 0.000 15.8 0.001 84.2 0.83 0.81
15 0.004 0.000 16.2 0.001 83.8 0.84 0.81
16 0.004 0.000 15.2 0.001 84.8 0.84 0.81
Table 3.  D-study reliability estimates and variance components for the Person (P) × Item (I) : Country (C) 
design including interactions for the Stroke Riskometer with removing some countries or some items at a time.
Randomly removed
P (I:C) P × (I:C)
Gr Gaσ2 σ2 % σ2 %
2 countries 0.003 0.000 18.7 0.001 81.3 0.80 0.76
3 countries 0.003 0.000 18.9 0.001 81.1 0.80 0.76
6 countries 0.003 0.000 19.2 0.001 80.8 0.72 0.67
4 items 0.004 0.000 20.1 0.001 79.9 0.81 0.79
8 items 0.003 0.000 18.3 0.001 81.7 0.78 0.74
12 items 0.004 0.001 17.9 0.003 82.1 0.59 0.55
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The Stroke Riskometer demonstrated superior psychometric properties in assessing stroke risks in several 
studies compared to other available methods and  applications6,9–11. Since its introduction in 2014, this applica-
tion has become increasingly popular and widely  used11. However, before this current study, its cross-cultural 
validation was not conducted using robust psychometric methodology. Therefore, this study was novel in using 
G-Theory to examine psychometric properties of the Stroke Riskometer across different countries. The findings of 
this study have added evidence for reliability of the Stroke Riskometer across countries in estimating stroke risks.
A D-study was conducted in an attempt to evaluate reliability of the Stroke Riskometer for each country, as 
well as the impact of each country on the overall reliability of the Stroke Riskometer. Similar to another cross-
cultural validation study that applied G-Theory to evaluate the positive and negative syndromes scale for assess-
ment of psychotic symptoms across different  countries23, we have also iteratively removed each country from the 
analyses and observed the overall reliability estimates. If by removing a specific country the overall reliability 
would increase, this would provide indirect evidence that there may be a negative impact on the reliability of 
assessment in this specific country. However, there were no noticeable improvements of the overall reliability by 
removing countries in our study. Together, these findings demonstrated that the Stroke Riskometer is reliable to 
use for estimating the risk of stroke in different countries in the world.
Moreover, other D-study analyses removing one or more item(s) at a time were conducted in an effort to 
examine the impact of each individual item and group of items on the overall reliability of the Stroke Riskometer. 
This methodology is the best practice used by other studies employing G-Theory approach and demonstrated 
their usefulness in optimizing  measurements17. Our results indicated that removing individual items did not 
improve reliability of the Stroke Riskometer and made it worse in comparison to reliability estimates of the full 
scale. This finding showed that the Stroke Riskometer is the most reliable in measuring stroke risks using its 
current assessment format and included risk factors.
CTT is currently the dominant statistical method for examining reliability of an assessment. Earlier studies 
have employed CTT to estimate the reliability of the Stroke  Riskometer6,9. However, it seems that there has not 
been any research applying the CTT method to evaluate the cross-cultural validation for this application. There 
also seems to be no research using the CTT approach for examining this validation for different countries in a 
single analysis. Literature reviews indicated that most CTT studies that conducted cross-cultural validation of 
psychometric instruments were based on internal consistency (Cronbach’s alpha) and/or test–retest reliability 
coefficients from a specific  country25,26. Therefore, CTT methods are unable to evaluate error sources due to 
the effect of individual facets such as items, countries, and their interactions together in a single analysis. The 
application of G-Theory in this study demonstrated its superiority to CTT in assessing the reliability of the Stroke 
Riskometer. The G-Theory method used in this study estimated precisely all possible influences on reliability 
(country error, item nested in country error, and error in interactions between item, country and/or person) 
simultaneously, providing a more rigorous evaluation of the overall reliability, permitting generalizability of the 
Stroke Riskometer scores across sample population and countries.
Normally, in a generalizability study, the item facet is fixed because the same items of the assessment are used 
across all participants and all  circumstances16,17. However, in this study the item facet was set at infinite because 
the items used in different countries were translated into different languages. In the literature facets are commonly 
defined as infinite if a researcher is interested in generalizing their findings over a facet, for example, the country 
facet in the current  study23,24. Essentially, generalizing assessment scores over countries is the primary purpose 
of cross-cultural validation studies. Therefore, the current observational design was applied for the purpose of 
examining how translation of Stroke Riskometer items into different languages would impact on reliability. Our 
results show that the Stroke Riskometer’s scores were also generalizable across the set of translated assessment 
items and countries, which suggests that appropriately translating these items into different languages of other 
countries not included in the current study may be equally reliable.
Strengths and limitations. The main strength of the study was the relatively large and ethnically diverse/
mixed sample of the study population, including Caucasians (mostly from Australia, France, Italy, New Zealand, 
Russia, Ukraine, United Kingdom, the United States) and non-Caucasian people (Brazil, India, Kazakhstan, 
Malaysia, Nigeria). However, with this large sample size we were not able to evaluate the generalizability of the 
Stroke Riskometer stratified by ethnicity because the ethnicity-specific data were unbalanced between countries 
with many sample sizes being too small to ensure robustness of G-analyses. Future studies should replicate these 
analyses with adequate samples of culturally diverse participants including a larger number of countries. Gen-
erally, our results are in line with the notion that the effect of generalizability analysis depends on the number 
of countries, assessment items and the study population. Therefore, excluding one country or item from a very 
large population would have negligible impact on the analysis while excluding a country or item from a much 
smaller population might have a significant impact. We acknowledge that cultural beliefs might also influence 
the interpretation of and/or responses to the translated questions and such influence could be investigated by 
measuring differences in cultural beliefs. However, this study did not include such measures, which is a limita-
tion that can be addressed in future research. To the best of our knowledge there is no research literature sug-
gesting additional cross-national variation of the app that needs to be tested at this point. Should such evidence 
arise, the authors are committed to test it in a future study.
Conclusion
In conclusion, the findings of this study indicate that the Stroke Riskometer reliably captures stroke risk across 
countries. Thus, users can rely on its ability to assess their stroke risks, but as it is a novel stroke prevention strat-
egy, the Stroke Riskometer should continue to evolve and more research is needed to further enhance precision 
and validity of this useful instrument.
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Methods
Participants. Participants (n = 11,744) from 132 countries worldwide completed the Stroke Riskometer 
questionnaire. In order to have an adequate sample size for the generalizability analyses (G-analyses), we firstly 
selected countries where there were more than 100 completed stroke risk assessments. There were thirteen coun-
tries meeting this selection criterion (namely Australia, Brazil, France, India, Italy, Kazakhstan, Malaysia, New 
Zealand, Nigeria, Russia, Ukraine, United Kingdom, and the United States). We then randomly selected an equal 
number of 100 participants for each selected country. The study sample finally consisted of 1300 participants 
with 100 in each country, as shown in Fig. 4. Participants’ ages ranged from 20 to 89 (mean = 46.28; standard 
deviation SD = 14.96). There were 680 (52.3%) male and 620 (47.7%) female participants. Ethnic groups included 
64.2% European, 11.2% Asian, 8.1% Indian, 1.0% Polynesian, and 15·5% others. The study was approved by the 
Auckland University of Technology Ethics Committee (AUTEC Ref.#19/236) and carried out in accordance 
with the AUTEC guidelines and regulations. All participants provided their informed consent to participate in 
this research. We have no evidence to believe that people who provided the data were vulnerable since informed 
consent was obtained from them as they entered the data remotely over the internet. None of these participants 
contacted us after they provided the data.
Measure. The Stroke  Riskometer6 consists of 21 assessment items including three demographic questions 
(i.e. age, sex, and ethnicities), two physical questions (height and weight), and 16 other questions identifying 
major risk factors of stroke including blood pressure. Dependent upon each individual item, some items use two 
categorical response options (0–1) and some three (0–2). For some items, a cut-off point is used to determine 
ordinal category. For instance, item 12 is recoded into 0 for participants who had blood pressure less than 120, 
and 1 for those who had that of 120 or above. G-analyses were conducted on the core 16 questions in the Stroke 
Riskometer included in Table  4. All 16 questions about physiological risk factors, including blood pressure, 
were also considered as risk factors, while age, sex, race/ethnicity, height and weight did not contribute to meas-
urement error because significant variability of these factors is not expected at the individual level. Therefore, 
stratification by sex and age were omitted because these variables cannot vary within an individual and cannot be 
interpreted differently in different countries. However, other physiological risk factors, including blood pressure 
may vary substantially within each individual and may substantially increase error variance.
Data analyses. EduG 6.1-e software (Swiss Society for Research in Education Working Group 2006) was 
used to conduct Generalizability analyses. Both G-study and D-study used the two-facet nested design where 
facet item (I) is nested in facet country (C) and person (P) was the object of measurement (differentiation facet), 
expressed as P × (I:C)15,27,28. In this study design, the I facet was infinite as were the P and C facets because the set 
of items used in different countries were translated into different languages. The facet P reflected true differentia-
tion amongst persons and was not a source of error in a generalizability study meaning that after controlling for 
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Generally, for the two-facet design, expressed as P × I × C, the effects for all facets were presented by X which 
was the observed score of a person on a particular item across countries and were obtained as  below15,24:
where : µ = grand mean of X, Xp = μp − μ (person effect), Xi = μi – μ (item effect), Xc = μc – μ (country effect), 
Xpi = μpi – μp – μi + μ (person × item effect), Xpc = μpc − μp − μc + μ (person × country effect), Xic = μic − μi − μc + μ 
(item × country effect), Xpic = μpic − μpi − μpc − μic + μp + μi + μc − μ (residual/person × item × country effect).
Each of the effects has estimated variance components, which were possible sources of error that might impact 
measurement and were calculated as follow with MS stands for the mean of effect squared and n represents a 
facet sample  size15,24:
Person variance component: σ2p =  (MSp −  MSpi −  MSpc +  MSpic)/ninc
Item variance component: σ2i =  (MSi −  MSpi −  MSic +  MSpic)/npnc
Country variance component: σ2c =  (MSc −  MSic −  MSpc +  MSpic)/ninc
Person × Item variance component: σ2pi =  (MSpi −  MSpic)/nc
Person × Country variance component: σ2pc =  (MSpc −  MSpic)/ni
Item × Country variance component: σ2ic =  (MSic −  MSpic)/np
Person × Item × Country variance component: σ2pic=MSpic.
However, this study was designed as the two-facet nested design with item facet nested in country facet and 
in this case the relevant variance components were obtained as  follows28:
Item nested in Country variance component: σ2(i:c) = σ2i + σ2pc
Residual/Person × Item nested in Country variance component: σ2px(i:c) = σ2ic + σ2pic
There are two reliability coefficients used in G-Theory: relative G-coefficient (Gr) and absolute G-coefficient 
(Ga). The relative model of measurement is a norm-referenced approach, which is based on a relative error vari-
ance ( σ 2δ  ). According to this model, a person’s assessment score is compared against the scores of  others30 and 
thus Gr is computed as  below15,28:
The absolute model of measurement is based on a criterion-referenced approach, where a person’s score is 
compared against some agreed-upon absolute  standard30. Ga accounts for an absolute error variance (σ2Δ) which 
involves interaction between country (C) and item nested in country (I:C) that possibly influences an absolute 
measurement  indirectly24,27,29:





























Table 4.  Sixteen stroke riskometer questions used in G-analyses.
Question Content
1 Do you currently smoke, or have you smoked over the past year?
2 Do you drink more than 1 standard alcoholic drink a day?
3 Do you eat at least 6 servings of fruits and/or vegetables a day?
4 Have you experienced significant mental/emotional stress or depression in the past year?
5 Did your mother or father have a stroke or heart attack before the age of 65?
6 What is your systolic blood pressure (the higher of the 2 numbers of your blood pressure reading)?
7 Are you using blood pressure lowering medication?
8 Have you ever been told by a doctor that you have diabetes?
9 Have you ever been told by a doctor you have any kind of heart disease?
10 Have you ever been told by a doctor that you have an enlarged heart?
11 Have you ever been told by your doctor that you have irregular heartbeats (atrial fibrillation)?
12 Have you ever been told by a doctor that you have a cognitive problem or dementia?
13 Do you or anyone close to you think you have poor memory?
14 Have you ever been told by a doctor that you have a traumatic brain injury?
15 Have you ever been told by a doctor that you’ve had a stroke or transient ischaemic attack (mini stroke)?
16 What is your systolic blood pressure (the higher of the 2 numbers of your blood pressure reading)?
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Both G coefficients (i.e., Gr and Ga) reflect reliability of a measurement with the measurement design where 
the differentiation facet is person (P). Specifically, Ga uses more stringent criteria and coefficients above 0.70 
reflect acceptable  reliability17, while Gr of 0.80 or higher indicates good reliability of assessment  scores29.
In the D-study, variance components were computed for each country and for further analyses to evaluate 
the impact of each country on the reliability of the Stroke Riskometer. In order to optimize reliability of the 
measurement we also examined if modification of measurement design (e.g., removing an item) may lead to 
enhanced reliability.
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